These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6942908)

  • 1. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children.
    Goorin AM; Borow KM; Goldman A; Williams RG; Henderson IC; Sallan SE; Cohen H; Jaffe N
    Cancer; 1981 Jun; 47(12):2810-6. PubMed ID: 6942908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiography in adriamycin cardiotoxicity.
    Bloom KR; Bini RM; Williams CM; Sonley MJ; Gribbin MA
    Cancer; 1978 Apr; 41(4):1265-9. PubMed ID: 273467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: role of radionuclide cardiac angiography.
    Agarwala S; Kumar R; Bhatnagar V; Bajpai M; Gupta DK; Mitra DK
    J Pediatr Surg; 2000 Dec; 35(12):1786-9. PubMed ID: 11101737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic assessment of left ventricular function during the injection of adriamycin.
    Björkhem G; Garwicz S
    Acta Paediatr Scand; 1977 Sep; 66(5):595-600. PubMed ID: 268924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography.
    Fatima N; Zaman MU; Hashmi A; Kamal S; Hameed A
    Nucl Med Commun; 2011 May; 32(5):381-5. PubMed ID: 21346663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic evaluation of adriamycin cardiotoxicity in children.
    Ramos A; Meyer RA; Korfhagen J; Wong KY; Kaplan S
    Cancer Treat Rep; 1976 Sep; 60(9):1281-4. PubMed ID: 1016964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
    Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP
    N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG; McKenzie WB; Alexander J; Sager P; D'Souza A; Manatunga A; Schwartz PE; Berger HJ; Setaro J; Surkin L
    Am J Med; 1987 Jun; 82(6):1109-18. PubMed ID: 3605130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors.
    Prout MN; Richards MJ; Chung KJ; Joo P; Davis HL
    Cancer; 1977 Jan; 39(1):62-5. PubMed ID: 188540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic findings in children treated for malignancy with chemotherapy including adriamycin.
    Solymar L; Marky I; Mellander L; Sabel KG
    Pediatr Hematol Oncol; 1988; 5(3):209-16. PubMed ID: 3152966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin cardiomyopathy--risk factors.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer; 1977 Apr; 39(4):1397-402. PubMed ID: 856438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cardiac monitoring with echocardiography in adult patients receiving adriamycin].
    Okada Y; Sano M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):823-7. PubMed ID: 12852350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adriamycin cardiomyopathy in a child with Wilms tumor and liver metastases (author's transl)].
    Stopfkuchen H; Gutjahr P
    Klin Padiatr; 1976 Sep; 188(5):459-63. PubMed ID: 184344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin (doxorubicin) cardiotoxicity: a review.
    Chlebowski RT
    West J Med; 1979 Nov; 131(5):364-8. PubMed ID: 394479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.
    Pein F; Sakiroglu O; Dahan M; Lebidois J; Merlet P; Shamsaldin A; Villain E; de Vathaire F; Sidi D; Hartmann O
    Br J Cancer; 2004 Jul; 91(1):37-44. PubMed ID: 15162142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.